NCT07048964 2025-07-03
A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic Medullary Thyroid Carcinoma With RET Gene Mutations
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting